Annual CFO
-$16.02 M
+$2.52 M+13.57%
December 31, 2023
Summary
- As of February 10, 2025, CGTX annual cash flow from operations is -$16.02 million, with the most recent change of +$2.52 million (+13.57%) on December 31, 2023.
- During the last 3 years, CGTX annual CFO has fallen by -$12.59 million (-366.59%).
- CGTX annual CFO is now -417.04% below its all-time high of -$3.10 million, reached on December 31, 2019.
Performance
CGTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$6.85 M
-$854.00 K-14.24%
September 30, 2024
Summary
- As of February 10, 2025, CGTX quarterly cash flow from operations is -$6.85 million, with the most recent change of -$854.00 thousand (-14.24%) on September 30, 2024.
- Over the past year, CGTX quarterly CFO has dropped by -$2.69 million (-64.65%).
- CGTX quarterly CFO is now -1392.64% below its all-time high of $530.00 thousand, reached on March 31, 2020.
Performance
CGTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$25.55 M
-$2.69 M-11.77%
September 30, 2024
Summary
- As of February 10, 2025, CGTX TTM cash flow from operations is -$25.55 million, with the most recent change of -$2.69 million (-11.77%) on September 30, 2024.
- Over the past year, CGTX TTM CFO has dropped by -$4.80 million (-23.15%).
- CGTX TTM CFO is now -4920.38% below its all-time high of $530.00 thousand, reached on March 31, 2020.
Performance
CGTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CGTX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.6% | -64.7% | -23.1% |
| 3 y3 years | -366.6% | -64.7% | -23.1% |
| 5 y5 years | -417.0% | -64.7% | -23.1% |
CGTX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -341.1% | +13.6% | -6883.2% | +32.7% | -603.6% | at low |
| 5 y | 5-year | -417.0% | +13.6% | -1392.6% | +32.7% | -4920.4% | at low |
| alltime | all time | -417.0% | +13.6% | -1392.6% | +32.7% | -4920.4% | at low |
Cognition Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.85 M(+14.2%) | -$25.55 M(+11.8%) |
| Jun 2024 | - | -$6.00 M(-17.2%) | -$22.86 M(+11.2%) |
| Mar 2024 | - | -$7.24 M(+32.8%) | -$20.56 M(+28.3%) |
| Dec 2023 | -$16.02 M(-13.6%) | -$5.46 M(+31.1%) | -$16.02 M(-22.8%) |
| Sep 2023 | - | -$4.16 M(+12.6%) | -$20.75 M(+25.1%) |
| Jun 2023 | - | -$3.70 M(+36.6%) | -$16.59 M(-9.1%) |
| Mar 2023 | - | -$2.71 M(-73.4%) | -$18.25 M(-1.5%) |
| Dec 2022 | -$18.53 M | -$10.18 M(>+9900.0%) | -$18.53 M(+124.7%) |
| Sep 2022 | - | -$4000.00(-99.9%) | -$8.25 M(-19.9%) |
| Jun 2022 | - | -$5.36 M(+79.3%) | -$10.29 M(+76.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.99 M(-3058.4%) | -$5.85 M(+61.0%) |
| Dec 2021 | -$3.63 M(+5.8%) | $101.00 K(-104.9%) | -$3.63 M(-13.8%) |
| Sep 2021 | - | -$2.05 M(+125.3%) | -$4.21 M(+34.9%) |
| Jun 2021 | - | -$910.00 K(+17.9%) | -$3.12 M(-34.0%) |
| Mar 2021 | - | -$772.00 K(+60.8%) | -$4.74 M(+37.9%) |
| Dec 2020 | -$3.43 M(+10.8%) | -$480.00 K(-50.1%) | -$3.43 M(+16.3%) |
| Sep 2020 | - | -$961.00 K(-61.9%) | -$2.95 M(+48.2%) |
| Jun 2020 | - | -$2.52 M(-575.8%) | -$1.99 M(-475.8%) |
| Mar 2020 | - | $530.00 K | $530.00 K |
| Dec 2019 | -$3.10 M | - | - |
FAQ
- What is Cognition Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Cognition Therapeutics?
- What is Cognition Therapeutics annual CFO year-on-year change?
- What is Cognition Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly CFO year-on-year change?
- What is Cognition Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Cognition Therapeutics?
- What is Cognition Therapeutics TTM CFO year-on-year change?
What is Cognition Therapeutics annual cash flow from operations?
The current annual CFO of CGTX is -$16.02 M
What is the all time high annual CFO for Cognition Therapeutics?
Cognition Therapeutics all-time high annual cash flow from operations is -$3.10 M
What is Cognition Therapeutics annual CFO year-on-year change?
Over the past year, CGTX annual cash flow from operations has changed by +$2.52 M (+13.57%)
What is Cognition Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CGTX is -$6.85 M
What is the all time high quarterly CFO for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly cash flow from operations is $530.00 K
What is Cognition Therapeutics quarterly CFO year-on-year change?
Over the past year, CGTX quarterly cash flow from operations has changed by -$2.69 M (-64.65%)
What is Cognition Therapeutics TTM cash flow from operations?
The current TTM CFO of CGTX is -$25.55 M
What is the all time high TTM CFO for Cognition Therapeutics?
Cognition Therapeutics all-time high TTM cash flow from operations is $530.00 K
What is Cognition Therapeutics TTM CFO year-on-year change?
Over the past year, CGTX TTM cash flow from operations has changed by -$4.80 M (-23.15%)